v3.24.3
CONDENSED STATEMENTS OF CASH FLOWS
$ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Operating activities    
Net income (loss) $ 3,144 $ (25,828)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Stock-based compensation expense 10,306 6,873
(Gain) loss on sale and disposal of fixed assets (23) 376
Depreciation and amortization 1,624 945
Net amortization of discount on short-term investments and term loans (433) (219)
Changes in assets and liabilities:    
Accounts receivable, net (25) 16,774
Inventories (1,161) (1,359)
Prepaid and other current and non-current assets (3,484) 5,329
Right-of-use assets 456 922
Accounts payable (3,327) 491
Accrued compensation (752) (773)
Accrued research and development 80 (1,954)
Revenue reserves and refund liability 6,508 2,398
Other accrued liabilities 4,566 (1,455)
Lease liability (511) (966)
Deferred revenue   (14)
Other current and long-term liabilities   (1,043)
Net cash provided by operating activities 16,968 497
Investing activities    
Maturities of short-term investments 32,950 35,650
Purchases of short-term investments (17,562) (18,222)
Capital expenditures (10)  
Payments for acquisition of intangible assets (360) (15,000)
Proceeds from sale of property and equipment 26 149
Net cash provided by investing activities 15,044 2,577
Financing activities    
Net proceeds from term loan financing   19,950
Net proceeds from issuances of common stock upon exercise of options 499 563
Closing purchase price payment related to asset acquisition (10,000)  
Cost share payments to a collaboration partner (3,605) (2,632)
Net cash (used in) provided by financing activities (13,106) 17,881
Net increase in cash and cash equivalents 18,906 20,955
Cash and cash equivalents at beginning of period 32,786 24,459
Cash and cash equivalents at end of period 51,692 45,414
Supplemental disclosure of cash flow information    
Interest paid 5,292 $ 4,167
Acquisition-related liabilities $ 5,000  

Source